eicosapentaenoic acid ethyl ester has been researched along with Psychoses in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study determined if augmentation of neuroleptics with 3 g/day of ethyl eicosapentaenoic acid (EPA) improves symptoms and cognition in patients with schizophrenia or schizoaffective disorder." | 9.09 | A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. ( Boronow, J; Dickerson, F; Fenton, WS; Hibbeln, JR; Knable, M, 2001) |
| "This study determined if augmentation of neuroleptics with 3 g/day of ethyl eicosapentaenoic acid (EPA) improves symptoms and cognition in patients with schizophrenia or schizoaffective disorder." | 5.09 | A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. ( Boronow, J; Dickerson, F; Fenton, WS; Hibbeln, JR; Knable, M, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wood, SJ | 3 |
| Cocchi, L | 1 |
| Proffitt, TM | 3 |
| McConchie, M | 3 |
| Jackson, GD | 2 |
| Takahashi, T | 1 |
| Pantelis, C | 2 |
| McGorry, PD | 3 |
| Berger, GE | 3 |
| Yuen, H | 1 |
| Amminger, GP | 2 |
| Brewer, W | 1 |
| Wellard, RM | 1 |
| Velakoulis, D | 1 |
| Fenton, WS | 1 |
| Dickerson, F | 1 |
| Boronow, J | 1 |
| Hibbeln, JR | 1 |
| Knable, M | 1 |
4 trials available for eicosapentaenoic acid ethyl ester and Psychoses
| Article | Year |
|---|---|
Neuroprotective effects of ethyl-eicosapentaenoic acid in first episode psychosis: a longitudinal T2 relaxometry pilot study.
Topics: Adolescent; Analysis of Variance; Double-Blind Method; Eicosapentaenoic Acid; Female; Hippocampus; H | 2010 |
Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Antipsychotic Agents; Double-Blind Method; Eicosapentaenoic Acid; Female; Humans; | 2007 |
Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study.
Topics: Adolescent; Adult; Brain; Brain Chemistry; Brain Mapping; Dietary Supplements; Double-Blind Method; | 2008 |
A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia.
Topics: Adult; Antipsychotic Agents; Cognition Disorders; Double-Blind Method; Drug Therapy, Combination; Ei | 2001 |